EU regulator backs Eisai-Biogen Alzheimer's drug

European committee takes a second look at Alzheimer’s drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with early Alzheimer's disease, nearly four months after it first rejected the treatment.
EU regulator reverses decision to block Alzheimer's drug lecanemab
The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at slowing cognitive decline in patients. In July, the Amsterdam-based European Medicines Agency (EMA) denied recommending approval of the drug made by Eisai and Biogen because it considered the risks - especially bleeding and swelling in the brain - to be greater than the potential benefits in a broad population.
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
EU drugs regulator recommends Alzheimer's drug from Eisai-Biogen
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with early Alzheimer's disease, months after the agency first rejected the treatment.
Changing course, European regulators now say Alzheimer’s treatment Leqembi should be approved
Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be approved.
Hosted on MSN5h
European Commission greenlights $4.3 billion for Ukraine
According to Shmyhal, the European Commission gave a positive assessment of Ukraine's ongoing reforms and noted that the ...
European Commission agrees to allocate €4.1 billion to Ukraine under Ukraine Facility programme
The European Commission has agreed to allocate €4.1 billion to Ukraine under the Ukraine Facility programme. Source: Prime ...
Politico Europe13h
Here’s the timeline for the new European Commission
European Parliament lawmakers have put Ursula von der Leyen’s 26 commissioner nominees through the wringer for nearly 80 ...
Courthouse News Service13h
Political hostage-taking delays European leadership approval
Feuding groups have postponed votes on European Commission President Ursula von der Leyen's picks to lead the EU's executive ...
European Commission approves $4.3 billion for Ukraine under Ukraine Facility program
"As we're approaching the 1000th day of Russia's atrocious war, we will help keep the Ukrainian state running while the ...
Risk27m
EU bonds favoured over swaps as hedge for European debt
Bonds issued by the European Commission are increasingly being used as proxy hedges to European government bonds rather than ...
RBC Ukraine on MSN11h
European Commission approves allocation of over €4 billion to Ukraine under Ukraine Facility
The European Commission has approved the allocation of 4.1 billion euros to Ukraine. These funds will be provided under the ...
Новости Украины14h
European Commission agrees to allocate EUR 4.1 billion to Ukraine within Ukraine Facility
The European Commission has agreed to allocate EUR 4.1 billion to Ukraine within the framework of the Ukraine Facility ...
EURACTIV1h
Commission must hold EU countries to account on climate obligations
Many National Energy and Climate Plans (NECPs) including those of France, Germany, Italy, Sweden and Ireland breach EU law - ...